Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 932 shares, a decline of 35.5% from the February 26th total of 1,444 shares. Based on an average daily volume of 1,248 shares, the short-interest ratio is presently 0.7 days.
Alvotech Stock Performance
Shares of NASDAQ:ALVOW opened at $0.20 on Friday. The business has a 50 day moving average price of $0.37 and a 200 day moving average price of $0.79. Alvotech has a twelve month low of $0.15 and a twelve month high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Recommended Stories
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
